Skip to content

Moderna, Pfizer Variant-Targeting Covid Boosters Get EU Nod

Vials of the Moderna Covid-19 vaccine.

Vials of the Moderna Covid-19 vaccine.

Photographer: Veejay Villafranca/Bloomberg

Europe’s drug regulator recommended the use of two omicron-tailored vaccines developed by the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. ahead of a fresh booster program this fall across the continent. 

The two shots, which both target the original coronavirus and the BA.1 subvariant, can be used as boosters for fully vaccinated people aged 12 years and above, the European Medicines Agency in a statement on Thursday.